In a recent paper, published in the journal Cell Death and Differentiation, Dr. Paul and his colleagues conclude that atypical protein kinase c lambda / iota holds «tremendous»
promise for treating breast cancer.
A team at the University of Kansas School of Medicine has identified a potential
target for treating breast cancer, including a particularly deadly form of the disease.
Gerry Potter and Ray McCague of the Institute of Cancer Research in Surrey based their design strategy on tamoxifen, a drug widely
used for treating breast cancer.
And the latest research suggests that this powerful duo could be a promising
therapy for treating breast cancer cells, when used along with standard anti-hormonal therapy.
While additional research is still required to determine just how useful pomegranates are
for treating breast cancer, it shows great promise in alleviating symptoms and fighting off breast cancer cells.